Myocardial Perfusion Study to Detect Coronary Microvascular Abnormality in Diabetic Patients With Nonfatal Myocardial Infarction

State University of New York - Upstate Medical University1 site in 1 country100 target enrollmentAugust 2011

ConditionsMyocardial Infarction

Overview

Phase: N/A
Intervention: Not specified
Conditions: Myocardial Infarction
Sponsor: State University of New York - Upstate Medical University
Enrollment: 100
Locations: 1
Primary Endpoint: Perfusion abnormalities in nondiabetic and diabetic patients
Status: Completed
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The goal of this study is to use MCE (myocardial contrast/perfusion echocardiography) to study and compare short/long term change of myocardial perfusion abnormality and cardiac outcome in diabetic patients after nonfatal MI (heart attack), who are treated with different glucose control agents.

Registry

clinicaltrials.gov

Start Date

August 2011

End Date

August 2017

Last Updated

4 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

State University of New York - Upstate Medical University

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Diabetic and nondiabetic patients will be initially recruited and studied after acute nonfatal MI and revascularization with either PCI or CABG

Exclusion Criteria

•Patients are excluded if they are older than 70 year old, require mechanical ventilation, are receiving intravenous pressors or hemodynamic support, or if the motion of segments associated with infarct-related artery can not be accurately determined.

Outcomes

Primary Outcomes

Perfusion abnormalities in nondiabetic and diabetic patients

Time Frame: short term (3 month) and long term (12 month).

Secondary Outcomes

The effect of different glycemic control strategies on the reduction of coronary injury in diabetic and non-diabetic subjects(short term (3 month) and long term (12 month))